{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:26:15Z","timestamp":1785252375406,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Anti-Mullerian hormone (AMH) has been recently identified as a potential predictor of live birth rates (LBRs) following assisted reproductive technology (ART) treatment. This study aimed to investigate the association between AMH levels and the outcomes of <jats:italic>in vitro<\/jats:italic> fertilization (IVF) in patients with polycystic ovary syndrome (PCOS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with PCOS initiating their first ovarian stimulation under the gonadotropin-releasing hormone antagonist protocol at the Guangdong Women and Children Hospital, China, were enrolled from November 2014 to September 2018.\u00a0A total of 157 patients who underwent fresh embryo transfer (ET) cycles were included in group A, whereas 187 patients who underwent frozen\u2013thawed ET cycles were included in group B. After the failure of the first ET cycle, 94 patients underwent the second ET cycle with frozen\u2013thawed embryos. Of these 94 patients, 52 had failed the first fresh ET cycle (group C) and 42 had failed the first frozen\u2013thawed ET cycle (group D). Successful embryo transfer was defined as live birth. This retrospective cohort study addressed the association between AMH levels and pregnancy outcomes using logistic regression approaches. After adjusting for age, body mass index, antral follicle counts, baseline follicle-stimulating hormone levels and baseline progesterone levels, LBRs were compared among the four groups and the cumulative live birth rate after two embryo transfers (TCLBR) was calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The LBRs showed no differences among the four groups. Higher serum AMH levels were found to be associated with a lower TCLBR [adjusted OR 0.937 (0.888\u20130.987), <jats:italic>P = 0.015<\/jats:italic>]. In patients who underwent the second ET cycle, LBRs were inversely proportional to AMH levels [crude OR 0.904 (0.828\u20130.986), <jats:italic>P = 0.022<\/jats:italic> versus adjusted OR 0.845 (0.754\u20130.946), <jats:italic>P = 0.004<\/jats:italic>, respectively]. In addition, the LBR was approximately 61%\u201378% lower in the group with AMH levels of &amp;gt;12 ng\/mL [crude OR 0.391 (0.168\u20130.912), <jats:italic>P = 0.030<\/jats:italic> versus adjusted OR 0.217 (0.074\u20130.635), <jats:italic>P = 0.005<\/jats:italic>, respectively].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Among PCOS patients high AMH level (&amp;gt;12 ng\/ml) is found to be associated with low TCLBR and low LBR of the second embryo transfer cycles. The results provide limited clinical inferences and warrant further investigation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1123125","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:02:36Z","timestamp":1686747756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["High anti-Mullerian hormone level is adversely associated with cumulative live birth rates of two embryo transfers after the first initiated cycle in patients with polycystic ovary syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Nianjun","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanxiao","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100494","article-title":"Changes in the prevalence of polycystic ovary syndrome in China over the past decade","volume":"25","author":"Yang","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-m\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa009","article-title":"Eshre guideline: ovarian stimulation for Ivf\/Icsi(\u2020)","volume":"2020","author":"Ovarian Stimulation","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3676","article-title":"Antim\u00fcllerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108493","article-title":"Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-mullerian hormone and antral follicle count measurements: a retrospective study","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.fertnstert.2019.03.022","article-title":"Low antim\u00fcllerian hormone (Amh) is associated with decreased live birth after In vitro fertilization when follicle-stimulating hormone and amh are discordant","volume":"112","author":"Ligon","year":"2019","journal-title":"Fertil Steril"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.10.021","article-title":"Antim\u00fcllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the society for assisted reproductive technology clinic outcome reporting system database for 2012-2013","volume":"109","author":"Tal","year":"2018","journal-title":"Fertil Steril"},{"key":"B10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2018.04.039","article-title":"Anti-m\u00fcllerian hormone levels are associated with live birth rates in art, but the predictive ability of anti-m\u00fcllerian hormone is modest","volume":"225","author":"Alson","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-m\u00fcllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.01.010","article-title":"Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-m\u00fcllerian hormone","volume":"32","author":"Ramezanali","year":"2016","journal-title":"Reprod BioMed Online"},{"key":"B13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12884-022-04518-0","article-title":"Association of antim\u00fcllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa008","article-title":"Low anti-m\u00fcllerian hormone level is not a risk factor for early pregnancy loss in Ivf\/Icsi treatment","volume":"35","author":"Peuranp\u00e4\u00e4","year":"2020","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12884-022-04591-5","article-title":"Serum anti-m\u00fcllerian hormone levels are associated with early miscarriage in the Ivf\/Icsi fresh cycle","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab168","article-title":"Amh highly correlates with cumulative live birth rate in women with diminished ovarian reserve independent of age","volume":"106","author":"Tal","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.01.024","article-title":"Association of serum anti-m\u00fcllerian hormone and other factors with cumulative live birth rate following ivf","volume":"40","author":"Hu","year":"2020","journal-title":"Reprod BioMed Online"},{"key":"B18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.fertnstert.2015.06.030","article-title":"Antim\u00fcllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization","volume":"104","author":"Hamdine","year":"2015","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2022.03.043","article-title":"Anti-m\u00fcllerian hormone is a predictor of medium-term cumulative live birth following in vitro Fertilization\/Intracytoplasmic sperm injection: a retrospective study","volume":"272","author":"Kien Nguyen","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-019-0498-3","article-title":"Ivf outcomes of women with discrepancies between age and serum anti-m\u00fcllerian hormone levels","volume":"17","author":"Zhang","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (Amh): correlation of amh with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der037","article-title":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","year":"2011","journal-title":"Hum Reprod"},{"key":"B25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"B26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s1472-6483(10)60042-9","article-title":"Symposium: update on prediction and management of ohss. a modern classification of ohss","volume":"19","author":"Golan","year":"2009","journal-title":"Reprod BioMed Online"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.673284","article-title":"High serum anti-m\u00fcllerian hormone concentrations are associated with poor pregnancy outcome in fresh Ivf\/Icsi cycle but not cumulative live birth rate in pcos patients","volume":"12","author":"Guo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2021.1962819","article-title":"Pregnancy outcome of freeze thaw cycles of polycystic ovary syndrome patients regarding the anti-m\u00fcllerian hormone percentile","volume":"42","author":"Arslanca","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.728051","article-title":"Independent variables for determining the cumulative live birth rates of aged patients with polycystic ovary syndrome or tubal factor infertility: a retrospective cohort study","volume":"12","author":"Guan","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.02.004","article-title":"Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-m\u00fcllerian hormone levels","volume":"39","author":"Valdimarsdottir","year":"2019","journal-title":"Reprod BioMed Online"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20490","DOI":"10.1038\/s41598-021-99850-4","article-title":"Association between baseline Lh\/Fsh and live-birth rate after fresh-embryo transfer in polycystic ovary syndrome women","volume":"11","author":"Su","year":"2021","journal-title":"Sci Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1123125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:02:39Z","timestamp":1686747759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1123125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":32,"alternative-id":["10.3389\/fendo.2023.1123125"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1123125","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]},"article-number":"1123125"}}